Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 376 for “"antipsychotics"”.

  1. Antipsychotics Prescribing and Ethnicity

    … States) showing differences in prescribing of antipsychotics for ethnic minorities, have prompted United Kingdom studies investigating any prejudicial prescribing of antipsychotics. Identified differences include use of high doses, more frequent use of older drugs and depot formulations, …

    kings Repository record for Antipsychotics Prescribing and Ethnicity (opens in a new tab) Download PDF for Antipsychotics Prescribing and Ethnicity (opens in a new tab)

  2. Antipsychotics, glutamate, and the brain

    … healthy volunteers; 4) investigate the effect of antipsychotics on glutamate levels in the anterior cingulate cortex (ACC) and clinical response using 1H-MRS in first-episode psychosis patients. <br/><br/>This thesis uses data from the Precision in Neuroimaging (PIN) study, a longitudinal study …

    kings Repository record for Antipsychotics, glutamate, and the brain (opens in a new tab) Download PDF for Antipsychotics, glutamate, and the brain (opens in a new tab)

  3. Adult Patients with Schizophrenia and Noncompliance with Antipsychotics

    Greater than half of the population of patients with schizophrenia struggle to comply with their antipsychotic medications due to various factors. Psychiatric providers heavily rely on their patients to comply with their antipsychotic medications to improve their overall quality of life. The …

    arizona-thes Repository record for Adult Patients with Schizophrenia and Noncompliance with Antipsychotics (opens in a new tab)

  4. Safety of Atypical Antipsychotics in the Elderly with Parkinson’s Disease

    … limited data exists regarding safety of atypical antipsychotics in general and inappropriate atypical antipsychotics in specific in patients with PD. This study evaluated the incidence and predictors of inappropriate atypical antipsychotic agents among older patients with PD; and the risks of …

    houston Repository record for Safety of Atypical Antipsychotics in the Elderly with Parkinson’s Disease (opens in a new tab)

  5. Investigating the cognitive effects of atypical antipsychotics: The Noradrenergic hypothesis

    <P>IMPROVEMENT IN COGNITIVE FUNCTIONING (E.G. WORKING MEMORY) HAS BECOME ONE OF THE MOST IMPORTANT CLINICAL TARGETS IN THE TREATMENT OF SCHIZOPHRENIA. ATYPICAL ANTIPSYCHOTIC DRUGS ARE SUPERIOR FOR COGNITIVE IMPAIRMENTS IN SCHIZOPHRENIA THAN THE TYPICAL DRUGS.YET THE MECHANISM OF THE IMPROVEMENT …

    nus Repository record for Investigating the cognitive effects of atypical antipsychotics: The Noradrenergic hypothesis (opens in a new tab) Download file for Investigating the cognitive effects of atypical antipsychotics: The Noradrenergic hypothesis (opens in a new tab)

  6. Thinking Long-Term: Nursing Education on Long-Acting Injectable Antipsychotics

    … The development of long-acting injectable antipsychotics (LAIs) has positively impacted medication adherence, however, this treatment modality is still underutilized in practice due to barriers, such as physician and patient negative attitudes toward LAIs and lack of education. Nurses hold …

    usfca Repository record for Thinking Long-Term: Nursing Education on Long-Acting Injectable Antipsychotics (opens in a new tab)

  7. Mechanism of Action of Antipsychotics, Haloperidol and Olanzapine in vitro

    Schizophrenia affects 1-1.5% of people in the United States alone. Haloperidol (HP), a butyrophenone and a typical antipsychotic, has been used as an antipsychotic drug in human. Unfortunately, the therapeutic effects of HP also come with severe extrapyramidal side effects, resulting in movement …

    vt Repository record for Mechanism of Action of Antipsychotics, Haloperidol and Olanzapine in vitro (opens in a new tab)

  8. Discontinuation of antipsychotics among residents of saskatchewan long-term care facilities

    Background and Objectives: Antipsychotic medications (APMs) are used for the treatment of behavioural symptoms of dementia. The use of APMs among residents of long-term care facilities (LTCFs), who have a high probability of dementia, is correspondingly high, and has been linked to adverse patient …

    sask Repository record for Discontinuation of antipsychotics among residents of saskatchewan long-term care facilities (opens in a new tab)

  9. The Effects of Atypical Antipsychotics on Implicit Reward Learning in Schizophrenia

    … used to treat the disorder (i.e., atypical antipsychotics) enhance, depress, or have no appreciable effect on this ability. Implicit reward learning performance was measured in three groups (controls [N = 19]; unmedicated [N = 26] and medicated [N = 21] first-episode schizophrenia patients) …

    queens Repository record for The Effects of Atypical Antipsychotics on Implicit Reward Learning in Schizophrenia (opens in a new tab)

  10. Evaluating medication utilization patterns and healthcare outcomes in patients receiving antipsychotics

    Several atypical antipsychotics have entered the market since the last decade. Evaluating the utilization patterns and overall cost savings generated by these expensive agents is becoming more important as their use continues to expand. Phase 1 of this study describes the patterns of antipsychotic …

    wvu Repository record for Evaluating medication utilization patterns and healthcare outcomes in patients receiving antipsychotics (opens in a new tab)

  11. Second-Generation Antipsychotics and Metabolic Side Effects in the Canadian Population

    The use of second-generation antipsychotic (SGA) has increased substantially in Canada over the last decade. Though an association has been found between SGAs and metabolic dysfunction in randomized controlled trials (RCTs), this information might not be generalizable to all SGA users. Furthermore, …

    calgary Repository record for Second-Generation Antipsychotics and Metabolic Side Effects in the Canadian Population (opens in a new tab)

  12. Educating Patients on Long Acting Injectable Antipsychotics to Improve Medication Adherence

    … of utilizing long-acting injectable antipsychotics (LAIAs). Background: Despite the critical importance of medication in managing psychotic disorders, nonadherence with routine medication regimes continues to be a major issue in mental healthcare. Due to its negative impact on …

    arizona-thes Repository record for Educating Patients on Long Acting Injectable Antipsychotics to Improve Medication Adherence (opens in a new tab)

  13. Perceptions and Practices of Administering Long-Acting Injectable Antipsychotics in Community Pharmacies

    Background: Use of long-acting injectable antipsychotics (LAIAs) for schizophrenia are associated with improved medication adherence and reduce relapse and hospitalizations compared to oral antipsychotics; however, despite these advantages LAIAs remain underutilized. Community pharmacies could …

    washington Repository record for Perceptions and Practices of Administering Long-Acting Injectable Antipsychotics in Community Pharmacies (opens in a new tab)

  14. Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand

    … associated with the cost-utility of atypical antipsychotics for the treatment of dementia patients. This thesis aims to use the cost-utility analysis to assess the economic impact of olanzapine compared with risperidone, for patients with BPSD in Thailand. The main stages applied for this …

    sheffield-hallam Repository record for Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand (opens in a new tab) Download PDF for Cost-effectiveness of atypical antipsychotics for the treatment of dementia in Thailand (opens in a new tab)

  15. Concomitant Use of Atypical Antipsychotics and Cholinesterase Inhibitors Among Older Adults with Dementia

    … to the concomitant use of AChEIs and atypical antipsychotics (classified as high versus low anticholinergic) among older adults with dementia; and (3) evaluate the risk of mortality due to the concomitant use of AChEIs and atypical antipsychotics (classified as high versus low anticholinergic) …

    houston Repository record for Concomitant Use of Atypical Antipsychotics and Cholinesterase Inhibitors Among Older Adults with Dementia (opens in a new tab)

  16. Glucagon-Like Peptide-1 Agonists to Manage Weight Gain in Patients Taking Antipsychotics [poster]

    … for weight management in patients taking antipsychotics. Liraglutide appeared to have the strongest support for efficacy. Studies frequently saw some patients drop out due to difficulty tolerating the gastrointestinal side effects of these medications. Further research is recommended on …

    texas-state Repository record for Glucagon-Like Peptide-1 Agonists to Manage Weight Gain in Patients Taking Antipsychotics [poster] (opens in a new tab)

  17. Interventions to Manage Weight Gain for Pediatric Population on Antipsychotics: A Systematic Review [poster]

    … and reduction of pediatric patients prescribed antipsychotics. Using PRISMA guidelines, various databases such as PubMed, CINAHL, PubMed Central and Medline were searched using key words of “weight gain,” “BMI,” antipsychotics,” “pediatrics,” “children,” “pharmacological,” “nonpharmacological,” …

    texas-state Repository record for Interventions to Manage Weight Gain for Pediatric Population on Antipsychotics: A Systematic Review [poster] (opens in a new tab)

  18. Interventions to Manage Weight Gain for Pediatric Population on Antipsychotics: A Systematic Review [paper]

    … and reduction of pediatric patients prescribed antipsychotics. Using PRISMA guidelines, various databases such as PubMed, CINAHL, PubMed Central and Medline were searched using key words of “weight gain,” “BMI,” antipsychotics,” “pediatrics,” “children,” “pharmacological,” “nonpharmacological,” …

    texas-state Repository record for Interventions to Manage Weight Gain for Pediatric Population on Antipsychotics: A Systematic Review [paper] (opens in a new tab)

  19. Dietary energy intakes in children with mental health conditions treated with second-generation antipsychotics

    … disorder, and depression. Second-generation antipsychotics (SGAs) are increasingly used to treat children with MHCs. Recent evidence suggests that SGAs are implicated in rapid weight gain, increased measures of adiposity, and cardiometabolic dysfunction in the pediatric population. The …

    ubc Repository record for Dietary energy intakes in children with mental health conditions treated with second-generation antipsychotics (opens in a new tab) Download PDF for Dietary energy intakes in children with mental health conditions treated with second-generation antipsychotics (opens in a new tab)

Page 1 of 19